In Situ Ablation of Hepatic Tumors

Surgical Innovation

Volumn 8, Issue 1, 2001, Pages 25-41

  Cuschieri, Alfred ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cryotherapy; Electroporation; Gene therapy; In situ ablation; Liver tumors; Sonoporation; Thermal ablation

Indexed keywords

ARTICLE; CRYOSURGERY; ELECTROPORATION; HUMAN; LAPAROSCOPY; LASER SURGERY; LIVER TUMOR; METHODOLOGY; PHOTOCHEMOTHERAPY; TEMPERATURE;

CRYOSURGERY; ELECTROPORATION; HUMANS; LAPAROSCOPY; LASER SURGERY; LIVER NEOPLASMS; PHOTOCHEMOTHERAPY; TEMPERATURE;

EID: 0035290821     PISSN: 15533506     EISSN: None     Source Type: Journal    
DOI: 10.1177/155335060100800104     Document Type: Article

References (82)

1. Office for National Statistics: Mortality statistics: Cause, England and Wales. London, Stationary Office, 1997
2. de Matteo R.P., Fong Y., Blumgart L.H.: Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 13:557-574, 1999
3. Kemeny N.E., Atiq O.T.: Non-surgical treatment for liver metastases. Baillieres Best Pract Res Clin Gastroenterol 13:593-610, 1999
4. Colorectal Cancer Collaborative Group: Palliative chemotherapy for advanced colorectal cancer: Systemic review and meta-analysis. BMJ 321:531-535, 2000
5. Zhou X.D., Tang Z.Y., Yu Y.O., et al: Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Cancer 61:1889-1892, 1988
6. Adam R., Majno P., Castaing D., et al: Treatment of irresectable liver tumours by percutaneous cryosurgery. Br J Surg 85:1493-1494, 1998
7. Kohli V., Clavien P.A.: Cryoablation of liver tumours. Br J Surg 85:1171-1172, 1998
8. Seifert J.K., Cozzi P.J., Morris D.L.: Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol 14:175-183, 1998
9. McKinnon J.G., Temple W.J., Wiseman D.A., et al: Cryosurgery for malignant tumours of the liver. Can J Surg 39:401-406, 1996
10. Dasappa V., Ross W.B., King J., et al: Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases. Int J Colorectal Dis 11:38-41, 1996
11. Ross W.B., Horton M., Bertolino P., et al: Cryotherapy of liver tumours: A practical guide. HPB Surg 8:167-173, 1995
12. Weaver M.L., Atkinson D., Zemel R.: Hepatic cryosurgery in the treatment of unresectable metastases. Surg Oncol 4:231-236, 1995
13. Hobbs K.E. Cryosurgery: its role in liver tumours. HPB Surg 7:89-91, 1993
14. El-Shaks S., Shimi S., Benson E.E., et al: Physical observations on rapid freezing of tumour cells to -40°C using differential scanning calorimetry. Cryo Lett 19:159-170, 1998
15. Cuschieri A., Crosthwaite G., Shimi S., et al: Hepatic cryotherapy for liver tumours: development and clinical evaluation of a high-efficiency multineedle probe system for open and laparoscopic use. Surg Endosc 9:483-489, 1995
16. Neel H.B., Ketcham S.A.: Current concepts in cryosurgery and cryoimmunology, in Zacharian S.A., Charles C.T. (eds): Cryosurgical Advances in Dermatology and Tumours of the Head and Neck. Springfield, IL, 1977, pp 250-261
17. Bayjoo P., Jacob G.: Hepatic cryosurgery: Biological and clinical considerations. J R Coll Surg Edinb 37:369-373, 1992
18. Soanes W.A., Ablin R.J., Gonder M.J.: Remission of metastatic lesions following cryosurgery in prostate cancer: Immunologic considerations. J Urol 104:154-156, 1970
19. Guresol E., Roberts M., Veenema R.J.: Regression of prostatic cancer following sequential cryotherapy to the prostate. J Urol 108:928-929, 1972
20. Wing M.G., Rogers K., Jacob G., et al: Characterisation of suppressor cells generated following cryosurgery of an HSV-2 induced fibrosarcoma. Cancer Immunol Immunother 26:169-172, 1988
21. Yamashita T., Hayakawa K., Hosokawa M. et al: Enhanced tumour metastases in rats following cryosurgery of primary tumour. Gann 73:222-224, 1982
22. El-Shakhs S.A., Shimi S.A., Cuschieri A.: Effective hepatic cryoablation: Does it enhance tumour dissemination? World J Surg 23:303-310, 1999
23. Lam C.M., Shimi S.M., Cuschieri A.: Thermal characteristics of a hepatic cryolesion formed in vitro by a 3-mm implantable cryoprobe. Cryobiology 36:156-164, 1998
24. Steger A.C., Lees W.R., Shorvon P., et al: Multiple-fibre low-power interstitial laser hyperthermia: Studies in the normal liver. Br J Surg 79:139-145, 1992
25. Steger A.C., Shorvon P., Walmsley K., et al: Ultrasound features of low power interstitial laser hyperthermia. Clin Radiol 46:88-93, 1992
26. Germer C.T., Albrecht D., Roggan A., et al: Technology for in situ ablation by laparoscopic and image-guided interstitial laser hyperthermia. Semin Laparosc Surg 5:195-203, 1998
27. Vogl T.J., Mack M.G., Muller P.K., et al: Interventional MR: Interstitial therapy. Eur Radiol 9:1479-1487, 1999
28. Schroder T., Castren-Persons M., Lehtinen A., et al: Percutaneous interstitial laser hyperthermia in clinical use. Ann Chir Gynaecol 83:286-290, 1994
29. Nolsoe C.P., Torp-Pedersen S., Burcharth F., et al: Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: A pilot clinical study. Radiology 187:333-337, 1993
30. Masters A., Steger A.C., Lees W.R., et al: Interstitial laser hyperthermia: A new approach for treating liver metastases. Br J Cancer 66:518-522, 1992
31. Bremer C., Allkemper T., Menzel J., et al: Preliminary clinical experience with laser-induced interstitial thermotherapy in patients with hepatocellular carcinoma. J Magn Reson Imaging 8:235-239, 1998
32. Sturesson C., Liu D.L., Stenram U., et al: Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rat. J Surg Res 71:67-72, 1997
33. Gewiese B., Beuthan J., Fobbe F., et al: Magnetic resonance imaging-controlled laser-induced interstitial thermotherapy. Invest Radiol 29:345-351, 1994
34. Matsumoto R., Mulkern R.V., Hushek S.G., et al: Tissue temperature monitoring for thermal interventional therapy: Comparison of T1-weighted MR sequences. J Magn Reson Imaging 4:65-70, 1994
35. Del Governatore M., Hamblin M.R., Shea C.R., et al: Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res 60:4200-4205, 2000
36. Siperstein A., Garland A., Engle K., et al: Laparoscopic radiofrequency ablation of primary and metastatic liver tumours. Surg Endosc 14:400-405, 2000
37. McGahan J.P., Browning P.D., Brock J.M., et al: Hepatic ablation using radiofrequency electrocautery. Radiology 168:313-317, 1988
38. McGahan J.P., Schneider P., Brock B.S., et al: Treatment of liver tumours by percutaneous radiofrequency electrocautery. Semin Interv Radiol 10:143-149, 1993
39. Rossi S., Fornari F., Buscarini L.: Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 8:97-103, 1993
40. Rossi S., Di Stasi M., Buscarini E., et al: Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1:73-81, 1995
41. Rossi S., Di Stasi M.D., Buscarini E.: Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Radiol 167:759-768, 1996
42. Buscarini L., Rossi S., Fornari F., et al: Laparoscopic ablation of liver adenoma by radiofrequency electrocautery. Gastrointest Endosc 41:68-70, 1995
43. Elias D., Goharin A., El Otmany A., et al: Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol 26:763-769, 2000
44. Siperstein A.E., Rogers S.J., Hansen P.D., et al: Laparoscopic thermal ablation of hepatic neuroendocrine tumour metastases. Surgery 122:1147-1155, 1997
45. Siperstein A.E., Garland A., Engle K., et al: Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumours. Ann Surg Oncol 7:106-113, 2000
46. Cuschieri A., Bracken J., Boni L.: Initial experience with laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumours. Endoscopy 31:318-321, 1999
47. Dong B.W., Liang P., Yu X.L., et al: Sonographically guided microwave coagulation treatment of liver cancer: An experimental and clinical study. AJR Am J Roentgenol 171: 449-454, 1998
48. Dong B.W., Liang P., Yu X.L., et al: Sonographically guided microwave ablation of liver tumour. ERC'99 - Presentation 217.
49. Ido K., Isoda N., Kawamoto C., et al. Laparoscopic microwave coagulation therapy for solitary hepatocellular carcinoma performed under laparoscopic ultrasonography. Gastrointest Endosc 45:415-420, 1997
50. Saitsu H., Nakayama T., Isomura T., et al: New endoscopic surgical treatment: Thoracoscopic microwave coagulo-necrotic therapy for small hepatocellular carcinoma. J Microw Surg 12:1-8, 1994
51. Hargreaves G.M., Adam R., Bismuth H.: Results after non-surgical local treatment of primary liver malignancies. Langenbecks Arch Surg 385:185-193, 2000
52. Vogl T.J., Muller P.K., Mack M.G., et al: Liver metastases: Interventional therapeutic techniques and results, state of the art. Eur Radiol 9:675-684, 1999
53. Vilana R., Bruix J., Bru C., et al: Tumour size determines the efficacy of percutaneous alcohol injection in the treatment of small hepatocellular carcinomas. Hepatology 16: 353-360, 1992
54. Cioni D., Lencioni R., Donati F., et al. Percutaneous treatment of small HCC: Radiofrequency thermal ablation versus ethanol injection - a randomized trial. ERC'99- Presentation 440.
55. Lencioni R., Rossi S., Garbagnati F., et al. Combined trans-catheter hepatic arterial occlusion / embolization and radiofrequency thermal ablation: A new therapeutic approach for large HCC. ECR'99 - Presentation 9-010.
56. Barkman C.A., Almquist L.O., Kirkhorn T., et al: Thermotherapy : Feasibility study using a single focussed ultrasound transducer. Int J Hyperthermia 15:63-76, 1999
57. Madersbacher S., Kratzik C., Susani M., et al: Minimally invasive therapy of benign prostatic hyperplasia with focussed ultrasound. Urologe A 34:98-104, 1995
58. Yang R., Kopecky K.K., Rescorla F.J., et al: Sonographic and computed tomography characteristics of liver ablation lesions induced by high-intensity focussed ultrasound. Invest Radiol 28:796-801, 1993
59. Scully S.P.: Gene therapy: Clinical considerations. Clin Orthop 379:S55-S58, 2000 (suppl)
60. de Roos W.K., de Wilt J.H., van der Kaaden M.E., et al: Isolated limb perfusion for local gene delivery: Efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas. Ann Surg 232:814-821, 2000
61. Anwer K., Meaney C., Kao G., et al: Cationic lipid-based delivery system for systemic cancer gene therapy. Cancer Gene Ther 7:1156-1164, 2000
62. Maheshwari A., Mahato R.I., McGregor J., et al: Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol Ther 2:121-130, 2000
63. Dass C.R., Walker T.L., Kalle W.H., et al: A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model. Drug Deliv 7:15-19, 2000
64. Omura S., Tsuyuki Y., Ohta S., et al: In vivo antitumor effects of electrochemotherapy in a tongue cancer model. J Oral Nlaxillofac Surg 57:965-972, 1999
65. Kuriyama S., Matsumoto M., Mitoro A., et al: Electrochemotherapy against colorectal carcinoma: Comparison of in vitro cytotoxicity of 5-fluorouracil, cisplatin and bleomycin. Int J Oncol 15:89-94, 1999
66. Dev S.B., Nanda G.S., An Z., et al: Effective electroporation therapy of human pancreatic tumors implanted in nude mice. Drug Deliv 4:293-299, 1997
67. Glass L.F., Fenske N.A., Jaroszeski M.J., et al: Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 3:82-86, 1996
68. Glass L.F., Jaroszeski M.J., Gilbert R.A., et al: Intralesional bleomycin-mediated electrochemotherapy in twenty patients with basal cell carcinoma. J Am Acad Dermatol 37:596-599, 1997
69. Glass L.F., Pepine M.L., Fenske N.A., et al: Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 132:1353-1357, 1996
70. Goldfarb P., Biel M., Hanna E., et al: A phase II study using electroporation (EPT) and intratumoral bleomycin in patients with recurrent head and neck cancer. A safe and active treatment approach. Proc ASCO 18:397A, 1999 (abstr)
71. Heller R., Jaroszeski M.J., Glass L.F., et al: Electrochemotherapy for the treatment of cutaneous malignancies. Proc Bioelectrochem Bioenergetics 141-142, 1996
72. Heller R., Jaroszeski M.J., Glass L.F., et al: Phase I / II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77:964-971, 1996
73. Hofmann G.A., Dev S.B., Dimmer S., et al: Electroporation therapy: A new approach for the treatment of head and neck cancer. IEEE Transactions on Biomedical Engineering 46:752-759, 1999
74. Hofmann G.A., Dev S.B., Nanda G.S., et al: Electroporation therapy of solid tumors. Crit Rev Ther Drug Carrier Syst 16:523-569, 1999
75. Panje W.R., Hier M.P., Garman G.R., et al: Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol 107:779-785, 1998
76. Sersa G., Kranjc S., Cemazar M.: Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Int J Radiat Oncol Biol Phys 46:1037-1041, 2000
77. Sersa G., Stabuc B., Cemazar M., et al: Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients. Clin Cancer Res 6:863-867, 2000
78. Zhang L.: From in vitro / in vivo model to feasibility study of potential medical applications: Pulsed electric field mediated transdermal drug / gene delivery. Proc IBC Int Conf Transdermal Drug Deliv, 1997
79. Nishi T., Dev S.B., Yoshizato K., et al: Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes. Human Cell 10:81-86, 1997
80. Jaroszeski M.J., Gilbert R.A., Nicolau C. et al; In vivo electroporation for the delivery of genes to normal liver and cancerous tissue. Proc Second World Congress Electricity Magnetism Biol Med 69, 1997
81. Dev S.B., Giordano F.J., Brown D.L.: Can endoluminal gene delivery by pulsed electric field overcome the current deficiencies of gene therapy for cardiovascular diseases? Proc Bioelectrochem Bioenergeties 113, 1996
82. Anwer K., Kao G., Proctor B., et al: Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther 7:1833-1839, 2000